Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions

The objective of this study was to investigate the influence of food on the bioavailability of omeprazole (20 mg) given as an enteric-coated tablet under repeated dose conditions. This ope...

Full description

Bibliographic Details
Main Authors: ABR Thomson, P Sinclair, A Matisko, E Rosen, T Andersson, B Olofsson
Format: Article
Language:English
Published: Hindawi Limited 1997-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1997/830856
id doaj-2fdf41df2a1b40c888fc1a57b5fe67a9
record_format Article
spelling doaj-2fdf41df2a1b40c888fc1a57b5fe67a92020-11-24T23:16:38ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79001997-01-0111866366710.1155/1997/830856Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose ConditionsABR Thomson0P Sinclair1A Matisko2E Rosen3T Andersson4B Olofsson5Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaAstra Pharma Inc, Mississauga, Ontario, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaAstra Hässle, Gothenburg, SwedenAstra Hässle, Gothenburg, SwedenAstra Hässle, Gothenburg, SwedenThe objective of this study was to investigate the influence of food on the bioavailability of omeprazole (20 mg) given as an enteric-coated tablet under repeated dose conditions. This open randomized crossover study consisted of three seven-day treatment periods, each separated by a drug-free period. During each treatment period an enteric-coated tablet of omeprazole was taken once daily either under fasting conditions, or immediately before or after a standardized breakfast. On the last day of each treatment period, blood samples for the determination of plasma omeprazole concentrations were collected at baseline and at predetermined intervals over the 24 h period following drug administration. Fifty-seven male and female subjects, aged 18 to 52 years, completed the study according to the protocol. No statistically significant differences were found when comparing either the before breakfast or after breakfast treatment regimens with the fasting regimen for the estimated mean area under the plasma concentration-time curve (AUC). The maximum plasma concentration was not found to differ significantly among any of the treatment regimens. However, the lower limit of the CI for the comparison of fasting/before breakfast was not contained within the limits of bioequivalence. The time to reach maximum plasma concentration was significantly different when fasting and after breakfast regimens were compared. Thus, under repeated dose conditions, food has no influence on the bioavailability (expressed as AUC) of omeprazole given as the enteric-coated tablet formulation.http://dx.doi.org/10.1155/1997/830856
collection DOAJ
language English
format Article
sources DOAJ
author ABR Thomson
P Sinclair
A Matisko
E Rosen
T Andersson
B Olofsson
spellingShingle ABR Thomson
P Sinclair
A Matisko
E Rosen
T Andersson
B Olofsson
Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
Canadian Journal of Gastroenterology
author_facet ABR Thomson
P Sinclair
A Matisko
E Rosen
T Andersson
B Olofsson
author_sort ABR Thomson
title Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
title_short Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
title_full Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
title_fullStr Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
title_full_unstemmed Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
title_sort influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 1997-01-01
description The objective of this study was to investigate the influence of food on the bioavailability of omeprazole (20 mg) given as an enteric-coated tablet under repeated dose conditions. This open randomized crossover study consisted of three seven-day treatment periods, each separated by a drug-free period. During each treatment period an enteric-coated tablet of omeprazole was taken once daily either under fasting conditions, or immediately before or after a standardized breakfast. On the last day of each treatment period, blood samples for the determination of plasma omeprazole concentrations were collected at baseline and at predetermined intervals over the 24 h period following drug administration. Fifty-seven male and female subjects, aged 18 to 52 years, completed the study according to the protocol. No statistically significant differences were found when comparing either the before breakfast or after breakfast treatment regimens with the fasting regimen for the estimated mean area under the plasma concentration-time curve (AUC). The maximum plasma concentration was not found to differ significantly among any of the treatment regimens. However, the lower limit of the CI for the comparison of fasting/before breakfast was not contained within the limits of bioequivalence. The time to reach maximum plasma concentration was significantly different when fasting and after breakfast regimens were compared. Thus, under repeated dose conditions, food has no influence on the bioavailability (expressed as AUC) of omeprazole given as the enteric-coated tablet formulation.
url http://dx.doi.org/10.1155/1997/830856
work_keys_str_mv AT abrthomson influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
AT psinclair influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
AT amatisko influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
AT erosen influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
AT tandersson influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
AT bolofsson influenceoffoodonthebioavailabilityofanentericcoatedtabletformulationofomeprazole20mgunderrepeateddoseconditions
_version_ 1725586572620857344